News and Highlights

Wednesday, 30 March 2022

40 Hours for the Forty Acres

40 Hours for the Forty Acres is a bi-annual, university-wide fundraising event that encourages everyone in The University of Texas at Austin community to give to the UT people, places and programs that are meaningful to them. For 40 hours, students, alumni, parents, faculty, staff and friends come together as a community and show their support. Cli...

Wednesday, 16 March 2022

Ben Liu Receives Norman R. Farnsworth Research Achievement Award

Congratulations to Professor Ben Liu, recipient of the the Norman R. Farnsworth Research Achievement Award by the American Society of Pharmacognosy (ASP). This award recognizes outstanding contributions in natural products research. Ben will present an award lecture at the annual ASP meeting in Charleston, SC, in July. 

Wednesday, 16 March 2022

Fatima Fakhreddine and Matt Worden Named Affordable Education Champions

Professor of Instruction Fatima Fakhreddine and Assistant Professor of Instruction Matt Worden been named Affordable Education Champions by the UT Natural Sciences Council in partnership with UT Libraries. Affordable Education Champions are student-nominated instructors who increase access and equity by selecting free or lo...

Tuesday, 08 March 2022

Zak Page Receives PMSE Young Investigator Award

Congratulations to Zak Page for being selected as an ACS PMSE Young Investigator awardee. Zak will present his work at a symposium at the fall national ACS meeting in Chicago.

Monday, 07 February 2022

Promising Drug Candidate Licensed to Cancer Therapeutics Company

AuraTEX, a gold-based cancer drug developed by University of Texas at Austin researchers, has been licensed exclusively to OncoTex Inc., a cancer therapeutics company. In 2020, UT Austin chemists Jonathan Sessler and Jonathan Araumbula (now CEO of OncoTex), published a paper in the Journal of the American Chemical Society showing that AuraTex preve...